RIGALLEAU, Vincent; PUCHEUX, Yann; COUFFINHAL, Thierry; TESSIER, Frederic J; HOWSAM, Michael; RUBIN, Sébastien; HELMER, Catherine; ALKHAMI, Fadi; LARROUMET, Alice; BLANCO, Laurence; BARBET-MASSIN, Marie-Amélie; FERRIERE, Amandine; MOHAMMEDI, Kamel; FOUSSARD, Ninon

doi:10.1016/j.diabet.2024.101600

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

RIGALLEAU, Vincent

Bordeaux population health [BPH]

PUCHEUX, Yann

COUFFINHAL, Thierry

Langue

Article de revue

Ce document a été publié dans

Diabetes & Metabolism. 2024-12-06, vol. 51, n° 1, p. 101600

Résumé en anglais

Since the pionneer work of Meerwaldt and the Groningen team, who related skin autofluorescence (SAF) to the dermal concentrations of advanced glycation end-products (AGEs), hundreds of articles have been devoted to its application in diabetes. Due to the slow turnover of the AGEs formed on collagen of the skin, the SAF can reflect the progressive accumulation of AGEs and hence be a marker of long-term glucose exposure. Accordingly, relations with HbA1c from the previous 3-10 years have been established in both type 1 and type 2 diabetes, and even in gestational diabetes mellitus. Other important determinants of SAF exist however, notably age, renal function, diet, and genetics. SAF is also related to current and future micro- and macrovascular complications of diabetes, as expected for a marker of glycemic memory. It is also related to some important emerging diabetes complications and comorbidities such as cancer, cognitive decline and liver disease. Quantitative information on glucose exposure during the previous years may be pertinent to personnalize care for patients with diabetes: priority for glucose control when SAF is low, and for screening for complications once SAF is high.< Réduire

Mots clés en anglais

Advanced glycation end-products

Diabetes complications

Skin autofluorescence

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications.

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

URI

DOI

Unités de recherche